Pre-made Melredableukin benchmark antibody ( Whole mAb, anti-Non-Binding therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Melredableukin biosimilar, Whole Mab: Anti-Non-Binding therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-682-1mg	1mg	3090
GMP-Bios-ab-682-10mg	10mg	Inquiry
GMP-Bios-ab-682-100mg	100mg	Inquiry
GMP-Bios-ab-682-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Melredableukin biosimilar, Whole Mab: Anti-Non-Binding therapeutic antibody
INN Name	Melredableukin
Target	Non-Binding
Format	Whole mAb Fusion
Derivation	Humanized
Species Reactivity	Human
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-I
Est. Status	Active
100% SI Structure	None
99% SI Structure	6ghg:HL
95-98% SI Structure	5ilc:HL
Year Proposed	2021
Year Recommended	na
Companies	Roche
Conditions Approved	na
Conditions Active	Ulcerative colitis
Conditions Discontinued	na
Development Tech	na